Exome sequencing results for the 43 novel candidate genes in general show no uniform biallelic inactivation, with only one gene- LLGL2- displaying biallelic inactivation in all sequenced tumours in the manner expected for a cancer predisposition gene (i.e. analogous to that seen for PALB2 in this study). The gene discussed is LLGL2; the disease is neoplasm.